Top Markets
#1 CoW Protocol CoW Protocol +65.62%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +35.94%
#4 Cysic Cysic +24.17%
#5 Nockchain Nockchain +15.44%
#6 Velvet Velvet +15.00%
#7 Humanity Humanity +14.65%
#8 The Black Bull The Black Bull +13.24%
#9 Tutorial Tutorial +12.75%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
CoW Protocol CoW Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Adiuvo Investments S.A. Adiuvo Investments S.A.

Adiuvo Investments S.A.

ADV
Rank in Stocks #37492
Adiuvo Investments S.A. operates as a venture capital firm, deploying capital... Adiuvo Investments S.A. operates as a venture capital firm, deploying capital across the entire spectrum of business development, from initial incubation and seed funding to supporting early-stage, startup, and growth-phase companies. Its primary investment focus lies in the medical devices, digital health, and nutraceuticals sectors, specifically targeting opportunities within Poland. The firm typically commits up to €3 million (approximately $3.35 million) per venture, with an intended holding period of three to five years. All investments are made directly from Adiuvo's own balance sheet. Established in 2013, the company maintains its headquarters in Warsaw, Poland.
Share Price
$0.12668455
Last synced: 2026-08-14
Market Cap
$1.67M
Change (1 day)
-4.26%
Change (1 year)
-43.21%
Country
PL
Trade Adiuvo Investments S.A. (ADV)

Category

Healthcare
Revenue for Adiuvo Investments S.A. (ADV)
Revenue in Aug 2026 TTM: 0
According to Adiuvo Investments S.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Adiuvo Investments S.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US